Baxter Inc, introduced new Altapore Shape Bioactive Bone Graft to be effectively used in surgery. It is designed with new configurations that give surgeons versatile options that are easy to mould and also to boost bone growth and help achieve fusion in surgeries involving the skeletal system.
Altapore Shape is used as a standalone bone graft substitute or as an autograft extender to fill bony voids or gaps in the skeletal system, including in the pelvis, extremities and posterolateral spine that are surgically created or result from trauma. Altapore Shape resorbs and is replaced with bone during the healling process and comes in four configurations – three cylinders of differing sizes (1.6 ml, 2.6 ml and 8 ml) and one strip (15.8 ml) – to aid surgeons in molding the product to fit various surgical needs.
The latest next-generation bone graft substitute is introduced to increase bone growth with optimized porosity that promotes earlier vascularisation, achieve fusion which in turn reduces pain and improves clinical outcomes for patients.
U.S. Food and Drug Administration (FDA) clearance of Altapore Shape Bioactive Bone Graft enables surgeons to give versatile tools as it works to advance the art of healling and improve clinical outcomes in the operating room.
